Borok M - Search Results

1

Pityriasis rubra pilaris. Further observations of systemic retinoid therapy.

Borok M, Lowe NJ. Borok M, et al. J Am Acad Dermatol. 1990 May;22(5 Pt 1):792-5. J Am Acad Dermatol. 1990. PMID: 2347965

2

Fish oil supplementation results in decreased hypertriglyceridemia in patients with psoriasis undergoing etretinate or acitretin therapy.

Ashley JM, Lowe NJ, Borok ME, Alfin-Slater RB. Ashley JM, et al. Among authors: borok me. J Am Acad Dermatol. 1988 Jul;19(1 Pt 1):76-82. doi: 10.1016/s0190-9622(88)70154-1. J Am Acad Dermatol. 1988. PMID: 2969924

3

Serum 8-methoxypsoralen (8-MOP) concentrations after bath water delivery of 8-MOP plus UVA.

David M, Lowe NJ, Halder RM, Borok M. David M, et al. Among authors: borok m. J Am Acad Dermatol. 1990 Nov;23(5 Pt 1):931-2. doi: 10.1016/s0190-9622(08)80698-6. J Am Acad Dermatol. 1990. PMID: 2254480 Clinical Trial. No abstract available.

4

Phototherapy units: comparison of fluorescent ultraviolet B and ultraviolet A units with a high-pressure mercury system.

Chue B, Borok M, Lowe NJ. Chue B, et al. Among authors: borok m. J Am Acad Dermatol. 1988 Apr;18(4 Pt 1):641-5. doi: 10.1016/s0190-9622(88)70084-5. J Am Acad Dermatol. 1988. PMID: 3372757

5

Fish oil consumption reduces hypertriglyceridemia in psoriatic patients receiving etretinate therapy.

Lowe NJ, Borok ME, Ashley JM, Alfin-Slater RB. Lowe NJ, et al. Among authors: borok me. Arch Dermatol. 1988 Feb;124(2):177-8. Arch Dermatol. 1988. PMID: 3341796 No abstract available.

6

Effects of 13-cis retinoic acid therapy on human antibody responses to defined protein antigens.

Sidell N, Connor MJ, Chang B, Lowe NJ, Borok M. Sidell N, et al. Among authors: borok m. J Invest Dermatol. 1990 Nov;95(5):597-602. doi: 10.1111/1523-1747.ep12505593. J Invest Dermatol. 1990. PMID: 2146325 Free article. Clinical Trial.

7

Recurrent cutaneous leishmaniasis.

Strick RA, Borok M, Gasiorowski HC. Strick RA, et al. Among authors: borok m. J Am Acad Dermatol. 1983 Sep;9(3):437-43. doi: 10.1016/s0190-9622(83)70156-8. J Am Acad Dermatol. 1983. PMID: 6630606

8

Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse transcriptase inhibitor therapy has failed (D²EFT): an open-label, randomised, phase 3b/4 trial.

D2EFT Study Group. D2EFT Study Group. Lancet HIV. 2024 May 21:S2352-3018(24)00089-4. doi: 10.1016/S2352-3018(24)00089-4. Online ahead of print. Lancet HIV. 2024. PMID: 38788744

9

Associations between antiretroviral regimen and changes in blood pressure: results from the D2EFT study.

Nyein PP, Petoumenos K, Borok M, Eriobu N, Kumarasamy N, Avihingsanon A, Azwa I, Dao S, Cisse M, Dharan NJ, Hanson J, Matthews GV. Nyein PP, et al. Among authors: borok m. Clin Infect Dis. 2024 May 9:ciae256. doi: 10.1093/cid/ciae256. Online ahead of print. Clin Infect Dis. 2024. PMID: 38721980

10

Differential effects of antiretroviral treatment on immunity and gut microbiome composition in people living with HIV in rural versus urban Zimbabwe.

Burkhart Colorado AS, Lazzaro A, Neff CP, Nusbacher N, Boyd K, Fiorillo S, Martin C, Siebert JC, Campbell TB, Borok M, Palmer BE, Lozupone C. Burkhart Colorado AS, et al. Among authors: borok m. Microbiome. 2024 Feb 3;12(1):18. doi: 10.1186/s40168-023-01718-4. Microbiome. 2024. PMID: 38310301 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page